BR112023014978A2 - Composições e métodos para o tratamento da doença do enxerto contra o hospedeiro - Google Patents

Composições e métodos para o tratamento da doença do enxerto contra o hospedeiro

Info

Publication number
BR112023014978A2
BR112023014978A2 BR112023014978A BR112023014978A BR112023014978A2 BR 112023014978 A2 BR112023014978 A2 BR 112023014978A2 BR 112023014978 A BR112023014978 A BR 112023014978A BR 112023014978 A BR112023014978 A BR 112023014978A BR 112023014978 A2 BR112023014978 A2 BR 112023014978A2
Authority
BR
Brazil
Prior art keywords
methods
host disease
compositions
treatment
versus host
Prior art date
Application number
BR112023014978A
Other languages
English (en)
Inventor
N Youssef Nader
Violetta Dimitriadou
Original Assignee
Vectivbio Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectivbio Ag filed Critical Vectivbio Ag
Publication of BR112023014978A2 publication Critical patent/BR112023014978A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/17—Lymphocytes; B-cells; T-cells; Natural killer cells; Interferon-activated or cytokine-activated lymphocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

composições e métodos para o tratamento da doença do enxerto contra o hospedeiro. a presente invenção refere-se a métodos de tratamento de doença de enxerto versus hospedeiro (gvhd), especificamente gvhd aguda e gvhd aguda gastrointestinal, utilizando apraglutida.
BR112023014978A 2021-01-28 2022-01-28 Composições e métodos para o tratamento da doença do enxerto contra o hospedeiro BR112023014978A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163142905P 2021-01-28 2021-01-28
US202163248074P 2021-09-24 2021-09-24
PCT/US2022/014349 WO2022165204A1 (en) 2021-01-28 2022-01-28 Compositions and methods for the treatment of graft versus host disease

Publications (1)

Publication Number Publication Date
BR112023014978A2 true BR112023014978A2 (pt) 2023-11-07

Family

ID=80461100

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023014978A BR112023014978A2 (pt) 2021-01-28 2022-01-28 Composições e métodos para o tratamento da doença do enxerto contra o hospedeiro

Country Status (9)

Country Link
US (2) US20220233645A1 (pt)
EP (1) EP4284410A1 (pt)
JP (1) JP2024507324A (pt)
KR (1) KR20230167019A (pt)
AU (1) AU2022212119A1 (pt)
BR (1) BR112023014978A2 (pt)
CA (1) CA3206093A1 (pt)
IL (1) IL304675A (pt)
WO (1) WO2022165204A1 (pt)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8421271B2 (en) * 2009-08-31 2013-04-16 General Electric Company Apparatus for transferring energy using onboard power electronics and method of manufacturing same
EP2314616A1 (en) 2009-10-23 2011-04-27 Ferring B.V. Peptidic GLP-2 agonists
CN113710692A (zh) * 2019-02-11 2021-11-26 Opko生物科学有限公司 长效glp-2类似物
WO2021252659A1 (en) 2020-06-09 2021-12-16 Vectivbio Ag Manufacture, formulation and dosing of apraglutide

Also Published As

Publication number Publication date
EP4284410A1 (en) 2023-12-06
IL304675A (en) 2023-09-01
JP2024507324A (ja) 2024-02-19
KR20230167019A (ko) 2023-12-07
AU2022212119A1 (en) 2023-08-10
AU2022212119A9 (en) 2024-05-16
US20220233645A1 (en) 2022-07-28
CA3206093A1 (en) 2022-08-04
WO2022165204A1 (en) 2022-08-04
US20240123036A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
JOP20210154B1 (ar) مثبطات kif18a
BR112019006876A2 (pt) anticorpos e composições anti-lag-3
MX2022001181A (es) Inhibidores de kif18a.
EA201890394A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ iRNA ДЛЯ ТРАНСТИРЕТИНА (TTR) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ ДЛЯ ЛЕЧЕНИЯ ИЛИ ПРЕДУПРЕЖДЕНИЯ АССОЦИИРОВАННЫХ С TTR ЗАБОЛЕВАНИЙ
MX2019010848A (es) Composiciones y procedimientos para el tratamiento del cancer.
EA201991071A1 (ru) Композиции и способы для лечения ezh2-опосредованного рака
EA201890961A1 (ru) Комбинированная терапия для лечения злокачественных новообразований
EA202091846A1 (ru) Соединения с активностью, индуцирующей ферроптоз, и способы их применения
CL2019002368A1 (es) Composiciones y métodos para el tratamiento de cáncer.
DOP2007000015A (es) Usos terapéuticos de inhibidores de rtp801
PH12018502056A1 (en) Methods of treatment of cholestatic diseases
NO20091661L (no) Anvendelse av pegylert IL-10 for a behandle kreft
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
EA202191630A1 (ru) ХИМИЧЕСКИ МОДИФИЦИРОВАННЫЕ КОНСТРУКЦИИ ДЛЯ RNAi И ПУТИ ИХ ПРИМЕНЕНИЯ
MX2022009596A (es) Anticuerpos anti-ror1 y composiciones.
EA202192122A1 (ru) Соединения, обладающие активностью индуцирования ферроптоза, и способы их применения
CL2021002681A1 (es) Inhibidores de la dihidroorotato deshidrogenasa.
BR112021022784A2 (pt) Composições e métodos para tratamento do câncer
MX2022001004A (es) Inhibidores de enzimas.
EA201200428A1 (ru) Композиция и способ для лечения ожирения
MX2023004869A (es) Anticuerpos contra sars-cov-2 y usos de los mismos.
BR112023014978A2 (pt) Composições e métodos para o tratamento da doença do enxerto contra o hospedeiro
BR112022012473A2 (pt) Composição de tratamento capilar, e, métodos para tratar cabelo, para melhorar a condição do cabelo e para diminuir o ph do cabelo
MX2021008716A (es) Metodo para tratar dolor de osteoartritis al administrar resiniferatoxina.
MX2018011025A (es) Metodos para tratar o prevenir la enfermedad del injerto contra huésped.